Annual Shareholders Equity
$92.08 M
-$11.82 M-11.38%
31 December 2023
Summary:
Aligos Therapeutics annual stockholders equity is currently $92.08 million, with the most recent change of -$11.82 million (-11.38%) on 31 December 2023. During the last 3 years, it has fallen by -$127.96 million (-58.15%). ALGS annual shareholders equity is now -58.15% below its all-time high of $220.04 million, reached on 31 December 2020.ALGS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$50.10 M
-$17.13 M-25.48%
30 September 2024
Summary:
Aligos Therapeutics quarterly stockholders equity is currently $50.10 million, with the most recent change of -$17.13 million (-25.48%) on 30 September 2024. Over the past year, it has dropped by -$4.72 million (-8.62%). ALGS quarterly shareholders equity is now -77.23% below its all-time high of $220.04 million, reached on 31 December 2020.ALGS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -8.6% |
| 3 y3 years | -58.1% | -76.9% |
| 5 y5 years | +769.8% | - |
ALGS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -58.1% | at low | -76.9% | at low |
| 5 y | 5 years | -58.1% | +241.9% | -77.2% | +136.7% |
| alltime | all time | -58.1% | +241.9% | -77.2% | +136.7% |
Aligos Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $50.10 M(-25.5%) |
| June 2024 | - | $67.23 M(+12.4%) |
| Mar 2024 | - | $59.80 M(-35.1%) |
| Dec 2023 | $92.08 M(-11.4%) | $92.08 M(+68.0%) |
| Sept 2023 | - | $54.82 M(-21.3%) |
| June 2023 | - | $69.64 M(-17.8%) |
| Mar 2023 | - | $84.75 M(-18.4%) |
| Dec 2022 | $103.90 M | $103.90 M(-14.8%) |
| Sept 2022 | - | $122.01 M(-10.9%) |
| June 2022 | - | $136.98 M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $152.89 M(-17.2%) |
| Dec 2021 | $184.73 M(-16.0%) | $184.73 M(-14.9%) |
| Sept 2021 | - | $217.01 M(+28.5%) |
| June 2021 | - | $168.88 M(-13.5%) |
| Mar 2021 | - | $195.22 M(-11.3%) |
| Dec 2020 | $220.04 M(-439.1%) | $220.04 M(-261.0%) |
| Sept 2020 | - | -$136.67 M(-212.1%) |
| June 2020 | - | $121.96 M(-287.9%) |
| Dec 2019 | -$64.89 M(+372.0%) | -$64.89 M |
| Dec 2018 | -$13.75 M | - |
FAQ
- What is Aligos Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aligos Therapeutics?
- What is Aligos Therapeutics annual shareholders equity year-on-year change?
- What is Aligos Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly shareholders equity year-on-year change?
What is Aligos Therapeutics annual stockholders equity?
The current annual shareholders equity of ALGS is $92.08 M
What is the all time high annual shareholders equity for Aligos Therapeutics?
Aligos Therapeutics all-time high annual stockholders equity is $220.04 M
What is Aligos Therapeutics annual shareholders equity year-on-year change?
Over the past year, ALGS annual stockholders equity has changed by -$11.82 M (-11.38%)
What is Aligos Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ALGS is $50.10 M
What is the all time high quarterly shareholders equity for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly stockholders equity is $220.04 M
What is Aligos Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ALGS quarterly stockholders equity has changed by -$4.72 M (-8.62%)